Late Soft Tissue Complications of Head and Neck Cancer Therapy: Lymphedema and Fibrosis

J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53):lgz005. doi: 10.1093/jncimonographs/lgz005.

Abstract

Head and neck cancer and its treatment result in soft tissue damage secondary to lymphedema and fibrosis. Lymphedema is the result of pathological accumulation of interstitial fluid in tissues. It is caused by the inability of the lymphatic system to transport lymph fluid from the tissues to the central circulatory system and is manifested clinically by tissue swelling. Fibrosis is defined as an overaccumulation of fibrotic tissues within the skin and soft tissues after a single or repetitive injury and is characterized by hardening of the soft tissues with associated loss of elasticity. Lymphedema and fibrosis are common yet overlooked late effects of head and neck cancer and its therapy. They may result in profound long-term symptom burden, loss of critical functions, and altered quality of life. The following review will discuss the current pathobiology, clinical manifestations, and future directions for research related to lymphedema and fibrosis.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Disease Management
  • Disease Susceptibility
  • Fibrosis
  • Genetic Predisposition to Disease
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / epidemiology
  • Head and Neck Neoplasms / genetics
  • Humans
  • Incidence
  • Lymphedema / diagnosis*
  • Lymphedema / epidemiology
  • Lymphedema / etiology*
  • Lymphedema / metabolism
  • Prevalence
  • Quality of Life
  • Symptom Assessment

Substances

  • Biomarkers